IMMX

Immix Biopharma, Inc. - Common Stock (IMMX)

About Immix Biopharma, Inc. - Common Stock (IMMX)

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Details

Daily high

$12.84

Daily low

$12.34

Price at open

52 Week High

$15.10

52 Week Low

$1.98

Market cap

894.2M

Dividend yield

Volume

13,810

Avg. volume

1.6M

P/E ratio

-14.20

Immix Biopharma, Inc. - Common Stock News